Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosyent Inc BIOYF


Primary Symbol: V.RX

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Bullboard (TSXV:RX)

View:
Comment by overnouton Dec 17, 2020 9:26am

RE:RE:Top Gainers

My bad, 330,000 share day
Comment by overnouton Dec 17, 2020 9:19am

RE:Top Gainers

It is hard to imagine volume picking up in any kind of considerble way. With a float of only 9.4M shares and the NCIB further reducing float count by 900K this ends up being a very illiquid stock ...more  
Post by retiredcfon Dec 17, 2020 7:51am

Top Gainers

We need more trading volume but this is the first time I can recall them cracking this list. GLTA Symbol/ Company Price $ Change $ Volume  ...more  
Comment by theinvestor22on Dec 16, 2020 7:11pm

RE:RE:RE:Combogesic

I look forward to the answer as well.  My guess is that Health Canada didn't think it needed to be a prescription medication, but that it needed couselling along with dispensing, hence it ...more  
Comment by overnouton Dec 16, 2020 4:10pm

RE:RE:Combogesic

I sent an email to Rene asking the question. I'll let you know. overnout
Comment by lscfaon Dec 16, 2020 1:59pm

RE:Combogesic

This product should be on the shelf next to Advil/Aspirin/Tylenol and not behind the counter. How do people become aware of it?     
Comment by Torontojayon Dec 16, 2020 1:02pm

RE:why

Not many people know about this company. Im more interested in companies that have fewer bullboard  participation than those flavour of the week/month stocks. 
Post by northernman59on Dec 16, 2020 11:39am

why

Why does the price and share value continue to stay so low.This company has marketed better products than a lot of companies and share price was at $10 year ago
Post by overnouton Dec 16, 2020 10:58am

Combogesic

Equilibrium may have to reajust. MISSISSAUGA, Ontario, Dec. 16, 2020 (GLOBE NEWSWIRE) --  BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce ...more  
Comment by overnouton Dec 16, 2020 10:42am

RE:RE:Share Buyback

It will be interesting to see at what price we achieve equilibrium for the NCIB. At what price do the sellers appear and at what price does Biosyent still believe that buying back shares represents ...more  
Comment by overnouton Dec 11, 2020 5:35pm

RE:Share Buyback

Nice. Should add a little zest to the stock price over time as it seems to have flatlined at $7 overnout
Comment by lscfaon Dec 11, 2020 10:02am

RE:Share Buyback

Cash on balance sheet was bringing down ROE.
Post by retiredcfon Dec 11, 2020 9:15am

Share Buyback

Always a sign that the company feels that their stock is undervalued. GLTA 09:03 AM EST, 12/11/2020 (MT Newswires) -- The TSXV has accepted BioSyent's Notice of Intention to Make a Normal ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities